AllerGen-CAAIF Emerging Clinician-Scientist Fellowship


AllerGen Scientific Director Dr. Judah Denburg (2nd from L) with Fellowship recipients (L to R) Dr. Moshe Ben-Shoshan, Dr. Marylin Desjardins and Dr. Philippe Bégin

Award Recipients: 2016 Ɩ 2014 Ɩ 2013 Ɩ 2011


There has been an alarming increase in the prevalence of allergy and immune-related diseases over the past 20 years, especially among children. Novel, patient-oriented diagnostic and treatment protocols are urgently needed, and there is a dire shortage of allergy and clinical immunology expertise in Canada.

AllerGen and the Canadian Allergy, Asthma and Immunology Foundation (CAAIF) share the fundamental goal of addressing this urgent need.

The AllerGen-CAAIF Emerging Clinician-Scientist Research Fellowship is a joint endeavour to support Canadian clinical immunologists and allergists in the pursuit of research training and a combined career as a clinician and academic researcher.


This Fellowship, one of the most prestigious in the country, provides the highest annual award value of any Fellowship in Canada. Its intention to train a new generation of leaders in allergy and immunology is strengthening the field.

Specifically, the AllerGen-CAAIF Emerging Clinician-Scientist Research Fellowship aims to:

  • strengthen the academic capacity of Canadian clinical immunology and allergy sub-specialists;
  • increase Canadian capacity for translational clinical immunology and allergy research; and
  • facilitate enhanced patient care through excellence in basic and clinical allergy and related immune disease research.

Since 2011, AllerGen has invested $1 million in support of four outstanding clinician-scientists:

2011 – Dr. Moshe Ben-Shoshan, MD, Pediatric Allergy and Immunology Specialist, Montreal Children’s Hospital; and Assistant Professor, Division of Allergy and Clinical Immunology, McGill University

2013 – Dr. Philippe Bégin, MD, Allergy and Clinical Immunology Specialist, Centre hospitalier de l’Université de Montréal; and Associate Researcher, Centre de recherche du Centre hospitalier de l’Université de Montréal

2014 – Dr. Marylin Desjardins, MD, Assistant Professor, Department of Pediatrics, McGill University

2016 – Dr. Catherine Biggs, MD, Allergist and Clinical Immunologist, BC Children’s Hospital, Emerging Clinician-Scientist Fellowship in progress

The first two recipients, having completed their Fellowships, have already gone on to develop new, highly impactful Canadian research programs.

Dr. Ben-Shoshan has spearheaded the nationwide Cross-Canada Anaphylaxis REgistry (C-CARE), the first prospective study on anaphylaxis to assess the rate, triggers and management of anaphylaxis in different provinces and settings across Canada. The unique registry has provided the first reliable estimate of anaphylaxis rates in Canada; identified which foods are the most common anaphylactic triggers for children and adults; quantified the annual incidence of recurrent anaphylaxis in children; and highlighted the frequency of accidental exposure to known allergens. As C-CARE expands across the country, it will open the door to new ways of preventing and treating anaphylaxis. In 2017, Dr. Ben-Shoshan was awarded the F. Estelle R. Simons Award for Research by the Canadian Society of Allergy and Clinical Immunology (CSACI).

Dr. Bégin has established a new clinic in Montreal’s Sainte-Justine Hospital offering oral immunotherapy (OIT) treatments to children with potentially life-threatening food allergies. A three-year pilot project at the clinic aims to bolster support—and to develop protocols and procedures for adoption by other treatment centres—for this promising form of therapy, which, though offered by private clinics in the US, has been largely unavailable in Canada. In 2017, Dr. Bégin was recognized with the CSACI’s Early Career Award.


The award provides up to $250,000 for a maximum of two years (an award of $100,000 plus a $25,000 research allowance each year) to a clinician who has completed clinical immunology and allergy sub-specialty training.

Eligible foci include basic and/or clinical research related to allergy, asthma and/or anaphylaxis. The quality of the research or training opportunity and the potential for a combined career as a clinician and researcher are the principal criteria on which applications are judged.

Details regarding the terms and conditions of funding, eligibility, evaluative criteria and the application process are all outlined in the Call for Applications below.

About CAAIF: The Canadian Allergy, Asthma, and Immunology Foundation (CAAIF) is a non-profit organization founded in 1995, to improve the quality of lives of Canadians by supporting allergy, asthma and clinical immunology research. Each year, CAAIF awards grants, and fellowships to leading Canadian researchers pursuing asthma, food allergy and related immune-related disease research with potential to improve the health of Canadians.

**NEW: Applicants who are scheduled to complete Clinical Immunology and Allergy sub-specialty training by December 31, 2019, are eligible to apply, subject to available funding and partnered support.

**NOUVEAU: Les candidats qui achèveront leur formation de sous-spécialité clinique en immunologie et allergologie d’ici le 31 décembre 2019 peuvent aussi poser leur candidature, sous réserve des fonds disponibles et du soutien des partenaires.

Competition Deadline

July 31, 2018

2018 Call for Applications: English | French

2018 Application Form (repost): English | French

2018 Applicant Statement Form (repost): English | French

For more information, please contact:

Leah Graystone
Highly Qualified Personnel (HQP) and Events Coordinator
AllerGen NCE Inc.
(905) 525-9140 x 26633